NYSE:STESteris Stock Price, Forecast & News

Steris' stock was trading at $145.25 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, STE stock has increased by 6.0% and is now trading at $154.01. View which stocks have been most impacted by Coronavirus.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Steris in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Steris.

Steris is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Steris.

Steris PLC (NYSE:STE) posted its quarterly earnings data on Wednesday, May, 13th. The medical equipment provider reported $1.64 EPS for the quarter, beating the consensus estimate of $1.57 by $0.07. The medical equipment provider earned $822.99 million during the quarter, compared to the consensus estimate of $788.37 million. Steris had a return on equity of 16.34% and a net margin of 13.45%. During the same quarter in the previous year, the firm posted $1.53 earnings per share. View Steris' earnings history.

Steris announced a quarterly dividend on Wednesday, May 13th. Stockholders of record on Friday, June 12th will be given a dividend of $0.37 per share on Friday, June 26th. This represents a $1.48 annualized dividend and a dividend yield of 0.96%. The ex-dividend date is Thursday, June 11th. View Steris' dividend history.

3 analysts have issued twelve-month target prices for Steris' stock. Their forecasts range from $170.00 to $170.00. On average, they expect Steris' share price to reach $170.00 in the next twelve months. This suggests a possible upside of 10.4% from the stock's current price. View analysts' price targets for Steris.

News stories about STE stock have been trending negative recently, according to InfoTrie. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Steris earned a news impact score of -2.2 on InfoTrie's scale. They also assigned media stories about the medical equipment provider a news buzz of 5.0 out of 10, meaning that recent press coverage is somewhat likely to have an impact on the company's share price in the immediate future. View the latest news about Steris.

Steris saw a drop in short interest during the month of June. As of June 30th, there was short interest totaling 1,240,000 shares, a drop of 8.8% from the June 15th total of 1,360,000 shares. Based on an average trading volume of 672,600 shares, the short-interest ratio is presently 1.8 days. Approximately 1.5% of the shares of the company are short sold. View Steris' Current Options Chain.

Some companies that are related to Steris include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton Dickinson and (BDX), Boston Scientific (BSX), Baxter International (BAX), Edwards Lifesciences (EW), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), Teleflex (TFX), Hologic (HOLX), Insulet (PODD) and Masimo (MASI). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Steris investors own include Johnson & Johnson (JNJ), Pfizer (PFE), AbbVie (ABBV), Home Depot (HD), Mastercard (MA), AT&T (T), Abbott Laboratories (ABT), Cisco Systems (CSCO), Gilead Sciences (GILD) and Mcdonald's (MCD).

Steris trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

Steris' stock is owned by many different institutional and retail investors. Top institutional shareholders include Nelson Van Denburg & Campbell Wealth Management Group LLC (0.00%) and Park National Corp OH (0.00%). Company insiders that own Steris stock include Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard Martin Steeves, Walter M Rosebrough Jr and Walter M Rosebrough, Jr. View institutional ownership trends for Steris.

STE stock was purchased by a variety of institutional investors in the last quarter, including Park National Corp OH, and Nelson Van Denburg & Campbell Wealth Management Group LLC. View insider buying and selling activity for Steris.

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of STE stock can currently be purchased for approximately $154.01.

Steris has a market capitalization of $13.08 billion and generates $3.03 billion in revenue each year. The medical equipment provider earns $407.61 million in net income (profit) each year or $5.64 on an earnings per share basis. Steris employs 13,000 workers across the globe.

The official website for Steris is www.steris.com.

Steris' mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The medical equipment provider can be reached via phone at 353-1232-2000 or via email at [email protected]